Message from the CEO
“The first quarter of the year began at a fast pace with much positive news.”
Jonas Jönmark, CEO, AcuCort AB
February 24, 2022
We make good drugs better
AcuCort develops innovative treatments based on existing and well-documented substances in treatment areas where there is a high unmet medical need and commercial interest in new drugs that add benefits such as simplicity of administration.